• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE SG; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE SG; IMPLANTABLE LEAD Back to Search Results
Model Number 0292
Device Problems Over-Sensing (1438); Pacing Problem (1439); Inappropriate/Inadequate Shock/Stimulation (1574); High Capture Threshold (3266)
Patient Problem Electric Shock (2554)
Event Date 03/31/2022
Event Type  Injury  
Event Description
It was reported that the patient with this implantable cardioverter defibrillator (icd) system received three inappropriate shocks and six anti-tachycardia pacing (atp) during an episode of atrial driven arrhythmia.Health care professional (hcp) consulted technical services (ts) who recommended reprogramming options.Later, there was a ventricular episode where atp was delivered due to oversensing of the right atrial (ra) lead signal on the ventricular channel.Ts analyzed device data and found that the rv output had increased to 6.5v.It was also noted that there were more rhythmiq episodes than expected due to device optimization.No additional adverse patient effects were reported.Currently, the lead remains in service.
 
Event Description
It was reported that the patient with this implantable cardioverter defibrillator (icd) system received three inappropriate shocks and six anti-tachycardia pacing (atp) during an episode of atrial driven arrhythmia.Health care professional (hcp) consulted technical services (ts) who recommended reprogramming options.Later, there was a ventricular episode where atp was delivered due to oversensing of the right atrial (ra) lead signal on the ventricular channel.Ts analyzed device data and found that the rv output had increased to 6.5v.It was also noted that there were more rhythmiq episodes than expected due to device optimization.No additional adverse patient effects were reported.Currently, the lead remains in service.According to additional information, this lead was surgically abandoned due to the aforementioned inappropriate shocks and high pacing thresholds.A new rv lead was successfully placed.No additional adverse patient effects were reported.According to additional information, a few days prior to procedure, there was an alert for shock into open circuit during an electric shock.
 
Event Description
It was reported that the patient with this implantable cardioverter defibrillator (icd) system received three inappropriate shocks and six anti-tachycardia pacing (atp) during an episode of atrial driven arrhythmia.Health care professional (hcp) consulted technical services (ts) who recommended reprogramming options.Later, there was a ventricular episode where atp was delivered due to oversensing of the right atrial (ra) lead signal on the ventricular channel.Ts analyzed device data and found that the rv output had increased to 6.5v.It was also noted that there were more rhythmiq episodes than expected due to device optimization.No additional adverse patient effects were reported.Currently, the lead remains in service.According to additional information, this lead was surgically abandoned due to the aforementioned inappropriate shocks and high pacing thresholds.A new rv lead was successfully placed.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDOTAK RELIANCE SG
Type of Device
IMPLANTABLE LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
*   00646-2602
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key17684477
MDR Text Key322654332
Report Number2124215-2023-48067
Device Sequence Number1
Product Code NVY
UDI-Device Identifier00802526531248
UDI-Public00802526531248
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P910073/S077
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 10/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date05/05/2020
Device Model Number0292
Device Catalogue Number0292
Device Lot Number435257
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/24/2023
Initial Date FDA Received09/05/2023
Supplement Dates Manufacturer Received10/02/2023
09/30/2023
Supplement Dates FDA Received10/04/2023
10/09/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/05/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age63 YR
Patient SexFemale
-
-